InflaRx: Funding, Investors & Team (Sep 2026)
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI USA.
InflaRx has raised $273M across 5 funding rounds on record, the most recent an undisclosed round of $150M announced in May 2026.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
InflaRx Company Profile and Key Stats
Latest funding round on record: May 2026.
InflaRx Funding Rounds
InflaRx raised $50.8M in a Grant announced in Oct 2021.
1.2 years later, an undisclosed round of $2.5M was announced in Dec 2022.
4 months later, an undisclosed round of $40.0M was announced in Apr 2023.
1.8 years later, an undisclosed round of $30.0M was announced in Feb 2025.
1.3 years later, an undisclosed round of $150M was announced in May 2026.
InflaRx Founders and Leadership Team
Contact details for the InflaRx team: 2 of 2 have an email address on file.
Start 14-day free trial →InflaRx Funding Compared to Other Health Care Startups
InflaRx's latest round of $150M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InflaRx in Health Care and Jena
Companies Similar to InflaRx
Arab Therapy functions as a startup that focuses on mental health.
Intu Diagnostics develops rapid and instrument-free solutions for infectious disease diagnostics, aiming for…
Maple Aviation is a medical logistics startup that specializes in building and operating autonomous drone…
Regulate is a wellness and performance company that provides science-backed breathwork programs and a mobile…
Avelios is a modular clinic platform that digitizes and optimizes all clinic processes in a user-friendly…
XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and…
Wellster is the go-to solution for everyday consumer health. It builds digital clinics along the lifecycle of…
Berlin Heals Holding is a developer of implantable medical device for the cure of heart failure.
Recare is reevaluating the process of discharge management by utilizing digital tools to improve…
Altavo operates as a medical device startup. Altavo harness the power of machine learning and…
Prosoma is a medical company creating digital therapeutics products for cancer patients. We develop a…
Mallia Innovations specializes in creating evidence-based hair regeneration solutions that target specific…
InflaRx Funding FAQs
What does InflaRx do?
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI USA.
How much funding has InflaRx raised?
InflaRx has raised $273M across 5 rounds on record. The most recent is an undisclosed round of $150M announced in May 2026.
When did InflaRx last raise funding?
InflaRx's most recent funding round on record is an undisclosed round of $150M, announced in May 2026.
Who founded InflaRx?
FundedIQ lists Niels Riedemann (Founder), Renfeng Guo (Founder) at InflaRx.
Where is InflaRx headquartered?
InflaRx is based in Jena, Thuringen, Germany.
How many employees does InflaRx have?
InflaRx is in the 51-100 employee band.
How does InflaRx's funding compare to other Health Care startups?
InflaRx's latest round of $150M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's InflaRx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InflaRx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.